These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6011 related articles for article (PubMed ID: 10655437)

  • 1. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
    Therasse P; Arbuck SG; Eisenhauer EA; Wanders J; Kaplan RS; Rubinstein L; Verweij J; Van Glabbeke M; van Oosterom AT; Christian MC; Gwyther SG
    J Natl Cancer Inst; 2000 Feb; 92(3):205-16. PubMed ID: 10655437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New guidelines to evaluate the response to treatment in solid tumors].
    Duffaud F; Therasse P
    Bull Cancer; 2000 Dec; 87(12):881-6. PubMed ID: 11174117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New guidelines to evaluate the response to treatment "RECIST"].
    Sasaki T
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2179-84. PubMed ID: 11142160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor response evaluation in oncology: current update.
    Shanbhogue AK; Karnad AB; Prasad SR
    J Comput Assist Tomogr; 2010 Jul; 34(4):479-84. PubMed ID: 20657213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring response in solid tumors: comparison of RECIST and WHO response criteria.
    Park JO; Lee SI; Song SY; Kim K; Kim WS; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Lee KS; Park K
    Jpn J Clin Oncol; 2003 Oct; 33(10):533-7. PubMed ID: 14623923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A statistical simulation study finds discordance between WHO criteria and RECIST guideline.
    Mazumdar M; Smith A; Schwartz LH
    J Clin Epidemiol; 2004 Apr; 57(4):358-65. PubMed ID: 15135836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response rates: a valuable signal of promising activity?
    Pivot X; Thierry-Vuillemin A; Villanueva C; Bazan F
    Cancer J; 2009; 15(5):361-5. PubMed ID: 19826354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outstanding problems with response evaluation criteria in solid tumors (RECIST) in breast cancer.
    Kimura M; Tominaga T
    Breast Cancer; 2002; 9(2):153-9. PubMed ID: 12016395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines.
    Prasad SR; Saini S; Sumner JE; Hahn PF; Sahani D; Boland GW
    J Comput Assist Tomogr; 2003; 27(3):380-4. PubMed ID: 12794603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of unidimensional and bidimensional measurement to assess therapeutic response in the treatment of solid tumors].
    Hauth EA; Stattaus J; Forsting M
    Radiologe; 2007 Jul; 47(7):628, 630-4. PubMed ID: 16440191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on criteria for assessing tumor response to treatment.
    Cruite I; Osman S; Dighe M
    Curr Probl Diagn Radiol; 2013; 42(5):209-19. PubMed ID: 24070714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QA procedures for multimodality preclinical tumor drug response testing.
    Lee YC; Goins BA; Fullerton GD
    Med Phys; 2010 Sep; 37(9):4806-16. PubMed ID: 20964200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARC-CTOS imaging symposium: introduction to the problem from a clinical perspective.
    Benjamin RS
    Oncologist; 2008; 13 Suppl 2():1-3. PubMed ID: 18434630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy in the assessment of tumor response in patients with pancreatic cancer: WHO versus RECIST criteria.
    Ahn SH; Garewal HS; Dragovich T
    J BUON; 2008; 13(3):359-62. PubMed ID: 18979550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria.
    Trillet-Lenoir V; Freyer G; Kaemmerlen P; Fond A; Pellet O; Lombard-Bohas C; Gaudin JL; Lledo G; Mackiewicz R; Gouttebel MC; Moindrot H; Boyer JD; Chassignol L; Stremsdoerfer N; Desseigne F; Moreau JM; Hedelius F; Moraillon A; Chapuis F; Bleuse JP; Barbier Y; Heilmann MO; Valette PJ
    Br J Radiol; 2002 Nov; 75(899):903-8. PubMed ID: 12466256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging response assessment in oncology.
    Curran SD; Muellner AU; Schwartz LH
    Cancer Imaging; 2006 Oct; 6(Spec No A):S126-30. PubMed ID: 17114065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical Trials.
    Feinberg BA; Zettler ME; Klink AJ; Lee CH; Gajra A; Kish JK
    JAMA Netw Open; 2021 Feb; 4(2):e2036741. PubMed ID: 33630085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tool support to enable evaluation of the clinical response to treatment.
    Levy MA; Rubin DL
    AMIA Annu Symp Proc; 2008 Nov; 2008():399-403. PubMed ID: 18998923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 301.